Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

A 34-year, named Adan (name changed), hailing from Ghana, South Africa adhering to Jehovah’s beliefs, presented with symptoms ...

They studied 36 FFPE samples from patients with meningioma—a common and benign brain tumor—and used a novel computational approach to integrate this data with nearly 1,300 publicly available ...

The Rotorua woman is going to the US this month for surgery and radiation, costing about $550,000. It was a “hard decision” ...

The patient - Adan (name changed) - presented with symptoms of left-sided weakness persisting for a year and headaches ...

A MUM was given just a week to live after doctors found a tumour that had been silently lurking in her brain for more than a decade. Harriet Annabelle Ward occasionally felt dizzy and tired but ...

They wanted to help but there wasn’t really anything they could confidently do.” Her family researched other treatment ...

Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...

They studied 36 FFPE samples from patients with meningioma – a common and benign brain tumor – and used a novel computational approach to integrate this data with nearly 1,300 publicly ...